Wilcoxia Spray is a topical analgesic formulation combining Mephenesin (10% w/w), Diclofenac (1.16% w/w), Lidocaine (2% w/w), Methyl Salicylate (5% w/w), Linseed Oil (3% w/w), and Menthol (5% w/w) designed for the symptomatic relief of musculoskeletal pain and inflammation. Mephenesin acts as a centrally acting muscle relaxant, reducing muscle spasms and associated discomfort. Diclofenac, a nonsteroidal anti-inflammatory drug (NSAID), provides potent anti-inflammatory and analgesic effects by inhibiting cyclooxygenase enzymes, thereby decreasing prostaglandin synthesis. Lidocaine, a local anesthetic, offers rapid onset analgesia by blocking sodium channels and interrupting nerve signal transmission. Methyl Salicylate and Menthol contribute counterirritant properties, producing a cooling sensation that distracts from deeper pain and enhances local blood flow. Linseed Oil serves as an emollient, aiding skin hydration and potentially supporting tissue repair. Wilcoxia Spray is intended for topical application over affected areas, facilitating targeted relief with minimal systemic absorption. It is suitable for conditions such as muscle strains, sprains, arthritis, and soft tissue injuries. Use should follow medical guidance to avoid adverse effects, particularly in patients with hypersensitivity to NSAIDs or local anesthetics. This combination offers a multi-modal approach to pain management, optimizing efficacy through synergistic pharmacological actions.